These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3501765)

  • 21. Immunization of SCID-Hu mice and generation of anti-hepatitis B surface antigen-specific hybridomas by electrofusion.
    Neil GA; Sammons DW
    Hum Antibodies Hybridomas; 1992 Oct; 3(4):201-5. PubMed ID: 1477301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An improved in vitro immunization procedure for the production of monoclonal antibodies.
    Boss BD
    Methods Enzymol; 1986; 121():27-33. PubMed ID: 3724466
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current developments in hybridoma technology].
    Osterhaus AD; UytdeHaag AG
    Tijdschr Diergeneeskd; 1985 Oct; 110(20):835-9. PubMed ID: 3878011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved fusion partners transfected with DNA fragment encoding IL-11 on generation of human B lymphocyte hybridomas.
    Zhu Y; Jin B; Jiang S; Sun K; Sun C; Liu X
    Hum Antibodies; 1999; 9(1):1-7. PubMed ID: 10331181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential production of monoclonal antibodies to carbohydrate moiety or peptides moiety of glycoproteins by different routes of immunization.
    Kimura A; Nakashima R; Inoue H; Yasuda S; Ikemoto E; Nishimoto K; Tsuji T
    Hybridoma; 1998 Jun; 17(3):245-50. PubMed ID: 9708826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dependence of T-cell-replacing factor and immunogenic dose for the production of monoclonal antibodies using the in vitro immunization technique.
    Borrebaeck CA
    Mol Immunol; 1984 Oct; 21(10):841-5. PubMed ID: 6334231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spleen cell analysis and optimal immunization for high-frequency production of specific hybridomas.
    Stähli C; Staehelin T; Miggiano V
    Methods Enzymol; 1983; 92():26-36. PubMed ID: 6304456
    [No Abstract]   [Full Text] [Related]  

  • 28. Human monoclonal anti-D secreting heterohybridomas from peripheral B lymphocytes expanded in the CD40 system.
    Thompson JM; Lowe J; McDonald DF
    J Immunol Methods; 1994 Sep; 175(1):137-40. PubMed ID: 7523524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6.
    Harris JF; Hawley RG; Hawley TS; Crawford-Sharpe GC
    J Immunol Methods; 1992 Apr; 148(1-2):199-207. PubMed ID: 1373425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production methods for generating human monoclonal antibodies.
    Glassy MC
    Hum Antibodies Hybridomas; 1993 Oct; 4(4):154-65. PubMed ID: 8257769
    [No Abstract]   [Full Text] [Related]  

  • 31. Establishment of B cell hybridomas with B cell surface antigens.
    Hamano T; Kim KJ; Leiserson WM; Asofsky R
    J Immunol; 1982 Oct; 129(4):1403-6. PubMed ID: 6809823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New strategies to establish human monoclonal antibodies.
    Kudo T; Saeki H; Saijyo S; Sato N; Numasaki M; Tachibana T
    Tohoku J Exp Med; 1992 Oct; 168(2):323-7. PubMed ID: 1306317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies in the development of human monoclonal antibodies.
    Jahn S; Grunow R; Kiessig ST; Settmacher U; Von Baehr R
    Dev Biol Stand; 1990; 71():3-7. PubMed ID: 2401386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Monoclonal antibodies produced by human-human hybridomas].
    Chida J
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Increase of lymphocytes producing antibodies against rabies virus, using intrasplenic adoptive transfer in mice treated with cyclophosphamide].
    Lara-Sagahon V; Ciprian CA; Aguilar-Setien A
    Arch Invest Med (Mex); 1989; 20(3):263-72. PubMed ID: 2633721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison and critical analysis of robotized technology for monoclonal antibody high-throughput production.
    Chiarella P; Leuener M; Fasci C; de Marco A; Santini MP; Fazio VM; Sawyer AM
    Biotechnol Prog; 2011; 27(2):571-6. PubMed ID: 21425250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro immunization for the production of antigen-specific lymphocyte hybridomas.
    Borrebaeck CA
    Scand J Immunol; 1983 Jul; 18(1):9-12. PubMed ID: 6192490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies to rat sarcomata. I. Immunization procedures and source of lymphoid cells for hybridoma production.
    North SM; Styles JM; Hobbs SM; Dean CJ
    Immunology; 1982 Nov; 47(3):397-405. PubMed ID: 7129525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-T lymphocyte interactions in experimental autoimmune myasthenia gravis: antigen presentation by rat/mouse hybridoma lines secreting monoclonal antibodies against the nicotinic acetylcholine receptor.
    Zhang YP; Tzartos SJ; Wekerle H
    Eur J Immunol; 1988 Feb; 18(2):211-8. PubMed ID: 2450756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.
    Lang AB; Fürer E; Senyk G; Larrick JW; Cryz SJ
    Hum Antibodies Hybridomas; 1990; 1(2):96-103. PubMed ID: 2129420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.